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Abstract 
Background and Aims: Reduction mammoplasty alleviates macromastia symptoms and 
improves quality of life. We investigated a large series of consecutive reduction 
mammoplasties to assess various risk factors for both minor and major complications after the 
procedure.    
Material and methods: A retrospective analysis of 453 consecutive reduction mammoplasties 
was performed between 2007 and 2010 at an academic tertiary referral center to evaluate risk 
factors and complications. 
Results: The incidence of minor and major complications was 40.5% and 8.8%, respectively. 
Patients with minor complications had both a significantly higher mean body mass index (BMI; 
30.2 vs 28.0) and sternal notch to nipple distance (33.9 cm vs 32.4 cm) than patients who 
recovered without complications (p<0.001 for both comparisons), as well as more visits to the 
outpatient clinic (p<0.001). In the multivariate analysis, BMI was found to be the only 
significant risk factor for minor complications (p<0.001). Further, patients with BMI higher 
than 27 had a 2.6-fold greater risk for minor complications (p<0.001). An increase of one unit 
in BMI increased the probability of minor complications by 14.1% (p<0.001). Twenty-two 
(4.9%) patients developed a hematoma requiring evacuation in the operating room. The 
mean BMI of patients that developed a hematoma was 26.4, a value lower than that of 
patients without this complication (mean 29.0; p=0.003). This finding was significant also in 
the multivariate analysis (p=0,002). 
Conclusions: A higher BMI was strongly associated with an increased risk of minor 
complications after reduction mammoplasty. It is important to inform obese patients about the 
increased risk for complications and to encourage them to lose weight before surgery. 
Keywords 
Reduction mammoplasty, body mass index, minor, major, complication 
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Introduction 
The loss of health-related quality of life (HRQoL) associated with symptomatic breast 
hypertrophy is well documented (1-3). Reduction mammoplasty (RM) is commonly performed 
to both reduce breast weight and volume, and reposition the breasts, which improves the 
HRQoL of the patient. Several randomized studies have demonstrated the effectiveness and 
cost-effectiveness of RM (1,4,5). The procedure is also reported to increase HRQoL regardless 
of the patient’s body mass index (BMI) (6). 
 
Complications of RM vary from minor wound complications to more severe complications, 
such as systemic infections, hematomas, and other wound complications that require 
reoperation. Potential factors exposing patients to these complications have been studied, but 
the results are still somewhat incoherent (6-16). In particular, the association between increased 
BMI and postoperative complications is unclear. Several studies report an increased risk of 
complications in patients with a high BMI, (6-14), whereas other studies report no such effect 
or only a weak association (15-19). Gust et al. (13) found that increased BMI increases the risk 
of surgical site complications, but the risk of major complications is unaffected. The benefits 
of the procedure in obese patients are proposed to far outweigh the added cost and suffering 
associated with surgical complications, and thus many authors recommend that RM should also 
be offered to this patient group (6,10,11,13). 
 
National guidelines of the indications for RM are published in several health care systems 
(17,20,21). In the Finnish health care system, obesity is not a contraindication for RM, but the 
Finnish guidelines suggest that a proper risk adjustment should be performed preoperatively. 
A BMI limit of 30-32 is widely used in the Finnish public healthcare system. Because of 
conflicting evidence, however, the association between BMI and surgical complications should 
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be further investigated. Here we aimed 1) to assess the incidence of minor and major 
complications after RM, and 2) to identify risk factors, especially the role of increased BMI, 
contributing to such complications. 
 
Material and Methods    
A total of 481 patients underwent RM (ICD codes HAD30 and HAD35) at Tampere University 
Hospital, an academic tertiary referral center, from 2007 through 2010. The clinical data were 
collected from medical records and analyzed retrospectively. Of 481 patients, 27 were excluded 
from the study because of breast cancer prior to surgery (n=21), male sex (n=4), 
and mastopexy instead of a reduction (n=2). Data concerning one patient was lost during 
analysis. The remaining 453 patients were included in this study. Data on patient 
demographics; preoperative sternal notch to nipple distance; comorbid conditions including 
diabetes, hypertension, and coronary heart disease; and postoperative complications were 
gathered from medical records. The Institutional review board of Tampere University Hospital 
approved the study. 
 
All patients underwent mammography and an ultrasound examination before surgery. 
Criteria set by the Finnish Ministry of Social Affairs and Health for indications for RM 
performed in public hospitals for health reasons were followed (21). These criteria indicate no 
exact BMI limit. While our institution mainly sets a BMI limit of 32, patients with higher BMI 
may also be operated on after risk adjustment following national guidelines (21). Smoking was 
considered a contraindication and all patients were expected to quit before the operation. The 
reduction technique was selected by the operative surgeon based on patient characteristics. 
Tampere University Hosipital is a teaching hospital. Thus, most operations were performed by 
plastic surgery residents under supervision. Complications after RM were assessed from the 
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medical records. Emergency plastic surgery in the whole Pirkanmaa Hospital District 
is organized at our institution, and thus it is highly likely that the vast majority of patients with 
complications were treated at our unit and thus documented in the medical records.  During the 
study period all patients were kept overnight after RM in our hospital. The number of re-
admissions to either the plastic surgery ward or the emergency ward, and additional visits at 
the outpatient clinic as well as the length of readmissions to the ward were recorded. Of the 
453 patients, only 6 (1.3%) did not attend any follow-up visits at the outpatient clinic.  
 
Complications were classified into two different categories: major and minor complications. 
Complications were classified major if the patient needed a reoperation or was readmitted to 
hospital for further treatment. Other complications treated on an outpatient basis were classified 
as minor. Major complications included hematoma; seroma; wound dehiscence; deep infection 
and necrosis of the nipple, areola, or wound requiring reoperation; and severe systemic or 
wound infection leading to hospitalization. Minor complications included delayed 
conservatively-treated wound healing, superficial wound infections, and lymphadenitis, as well 
as conservatively-treated hematomas, seromas, fat necrosis, necrosis of the nipple, areola, or 
wound. 
 
Statistical analysis of the collected data was performed using IBM SPSS Statistics Version 20. 
An unpaired t-test for Gaussian populations was used to investigate if hematomas requiring 
surgery, major complications and minor complications were associated with age, BMI, or 
sternal notch to nipple distance. A ci-square test for binominal variables was used to investigate 
if hematomas requiring surgery, major complications and minor complications were associated 
with hypertension, diabetes, and coronary heart disease. Analysis of variance (ANOVA) and 
post hoc tests were used to assess the effect of an increased BMI on the number of minor 
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complications (0, 1, or ≥2 complications). Receiver operating curve analysis and logistic 
regression analysis were used to study the association of BMI with minor complications and 
hematoma evacuations.  
 
Results 
Patient characteristics are presented in Table 1. Hypertension was the most common 
comorbidity. The patients were, on average, overweight (mean BMI value 28.9, range 18.6-
47.2); 80.2% (n=364) of the patients had a BMI lower than 32.0, 12.8% (n=58) had BMI a 
value of 32.0-34.9, and 6.8% (n=31) of the patients had BMI of 35 or higher. Almost half of 
the patients (44.3%, n=201) had at least one minor or major complication (Table 2). 
  
Major complications     
Forty (8.8%) patients had at least one major complication and four (0.9 %) patients had more 
than one major complication (Table 2). None of the patients were diagnosed with a deep venous 
thrombosis or pulmonary embolism. Twenty-two (4.9%) patients 
developed a hematoma requiring evacuation in the operating room. One of these patients had 
bilateral hematomas that both required evacuation. Evacuation of the hematoma was performed 
on the same day as the primary operation in 8 (36.4%) patients, the next day in 12 (54.5%) 
patients, and 2 days postoperatively in 2 (9.1%) patients. 
 
Sixteen (3.5%) patients were readmitted to the ward due to complications and two of these 
patients were readmitted twice. The mean length of the stay was 2.7 (SD 1.6) nights. There was 
no association between any of the major complications and sternal notch to nipple distance, 
age, diabetes, or hypertension. One of the three patients with coronary heart disease had a major 
complication. Mean preoperative BMI of the patients that developed a hematoma requiring 
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surgery was 26.4 (SD 3.0), a significantly lower value than that of 
patients without this complication (29.0, SD 4.2; p=0.003). Logistic regression analysis 
showed that an increase of one unit in BMI decreased the risk of a hematoma requiring surgery 
by 16.9% (odds ratio [OR] 0.83, confidence interval [CI] 0.73-0.94; p=0.004). This finding 
was also significant in the multivariate analysis (p=0.002) (Table 3). 
No other factors analyzed were associated with a hematoma requiring evacuation.  
   
Minor complications 
One-hundred and eighty-four (40.6%) patients had a minor complication and 39 of them (8.6% 
of all patients) had more than one minor complication (Table 2).  Patients who suffered a minor 
complication had both a higher mean BMI (30.2 vs. 28.0) and a longer mean sternal notch to 
nipple distance (33.9 cm vs. 32.4 cm) than patients without any minor complications (p<0.001 
for both comparisons). In the multivariate analysis, however, BMI was found to be the only 
significant risk factor for minor complications (p<0.001) (Table 4). Patients who had at least 
one minor complication also made more visits to the outpatient clinic (p<0.001). The mean 
number of visits was 1.23 (SD 1.74) for patients with a minor complication compared to a mean 
of 0.23 (SD 0.53) for those who experienced no complications. 
Further receiver operating curve analysis of the effect of BMI revealed an optimal cut-off point 
of 27.0. Patients with BMI higher than 27.0 had 2.6-fold higher odds for minor 
complications (OR 2.56, CI 1.68-3.90; p<0.001). The association between BMI and minor 
complications was further analyzed using a logistic regression analysis, which showed that an 
increase of one unit in BMI also increased the probability of minor complications by 14.1% 
(OR 1.14, CI 1.09-1.20; p<0.001). As patient BMI increased, the number of minor 
complications per patient increased significantly (p<0.05 for all comparisons).  
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Discussion 
A variety of guidelines exist regarding the indications for RM (20,21). The criteria include 
minimum cup size, resection weight, sternal notch to nipple distance, BMI, psychologic 
morbidity, and smoking habit. BMI is a good indicator for obesity and also predicts surgical 
complications (22). A BMI of 25-30 indicates overweight, 30-35 moderate obesity, 35-40 
severe obesity, and a BMI over 40 indicates very severe obesity. While we found no correlation 
between major complications and an increase in the BMI, a definite correlation between minor 
complications and an increase of BMI was detected. 
 
The association between sternal notch to nipple distance and complication rate is controversial. 
Some studies have reported a positive association (9,10). Manahan et al. (9) reported that a 
sternal notch to nipple distance greater than 37 cm was associated with increased rates of fat 
necrosis and minor wound complications, and a distance over 41 cm was associated with an 
increased risk of infections and major wound complications. Setälä et al. (10) found that the 
distance between the clavicle and areola was greater in patients with areola necrosis. Our results 
showed that the mean sternal notch to nipple distance was significantly higher among patients 
developing minor complications. Multivariate analysis, however, did not reveal this to be a 
significant risk factor.  Other studies have reported no connection (7,8,14,16,19).  
 
One interesting finding of the present study was that the mean BMI value among patients 
requiring evacuation of a hematoma was significantly lower than that in patients without this 
complication. The reason for this finding is unclear. Previous studies demonstrated an 
association between hypotension during anesthesia and an increased number of hematomas 
requiring hematoma evacuation (23,24). Due to the retrospective nature of the present study, 
these data were not collected. It is possible that breast tissue itself differs between overweight 
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and obese patients; i.e., there may be more vascular glandular tissue instead of fat tissue in 
patients with a lower BMI.  
 
Several studies have demonstrated a correlation between a higher BMI and postoperative 
complications after RM, consistent with our findings (6-14). Other studies, however, have 
reported an unclear connection (16-18) or no connection between preoperative BMI and post-
surgical complications (15,19). Zubowski et al. (18) reported a significant increase in the 
complication rates in obese patients. When the population was subdivided into five groups 
based on the degree of obesity, however, the correlation no longer held. The subgroups may 
have become too small for reliable analysis. The study by Eggert et al. (17) included no women 
with a BMI over 30. They observed a tendency toward more complications in the overweight 
group of patients (BMI 25-30), but were unable to draw any conclusions due to the small size 
of the group. Cunningham et al. (15) and Neaman et al. (19) found no connection between BMI 
and postsurgical complications. 
 
Chun et al. (6) suggested that patients with a BMI of ≥35.6 have significantly more 
postoperative complications overall. Manahan et al. (9) found that a BMI ≥35 increases the risk 
for infections, seromas, fat necrosis, and minor wound complications. Chen et al. (11) 
associated obesity (BMI>30) with a nearly 12-fold increase in the odds for postoperative 
complications after elective breast procedures. Stevens et al. (14) associated a BMI >27 with 
poor wound healing. Two large studies by Nelson et al. (12) and Gust et al. (13) using the 
National Surgical Quality Improvement database found a significant increase in the 
complication rates with increasing obesity classes. In our study, a correlation between BMI and 
complications was detected regarding minor, but not major, complications. This could be 
explained by the selection of patients. A BMI limit of 32 was used for the surgeries, and only 
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6.8% of the operated patients were severely or very severely obese (BMI>35). Moderate BMI 
value can also explain the low number of patients with diabetes and coronary artery disease. In 
contrast, the number of patients with hypertension was higher. No connection between 
hypertension and postoperative complications was detected, consistent with previous studies 
(6,9,11,13,17).  
 
The 40.5% rate of minor complications in the present study is high, but the 8.8% rate of major 
complications is fairly low. These results are consistent with previous studies (25-27). The risk 
for minor complications was found to increase already in patients with a BMI of 27. This cutoff 
point is quite low compared to that suggested in earlier studies, which reported an increase in 
the risk with BMI>26.3-40 (6,7,9,12-14). It seems that most of the complications related to 
RM are minor and thus it is a safe procedure for overweight patients. In addition, aesthetic 
outcome is also good in patients with higher BMI values (27). Only morbidly obese patients 
are at high risk for complications (10,12). The benefits of RM in terms of QoL far exceed the 
risk of prolonged healing due to minor complications. Based on these facts, several studies 
recommend no restrictions based on patient BMI despite the significant increase in 
complication rates with increasing obesity (10,12,13). Current opinion is that informing 
patients of the potential risks well in advance of the surgery is sufficient. On the other hand, 
our study showed that patients with minor complications have more additional visits to the 
hospital, thereby increasing costs. This has implications for both healthcare staff and healthcare 
payers. RM itself can be accepted for obese patients for medical reasons. Public health care 
resources, however, are limited and there should be guidelines regarding which operations 
should be performed in a public hospital. In this respect, the current BMI limit of 30-32 is not 
too strict.  
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A strength of this study is the fairly large study population representing all women operated on 
in the public sector during the study period, thereby improving the generalizability of the 
results. Because of the structure of the Finnish health care system, it is likely that all major 
complications requiring hospital treatment or reoperation were included. The low number of 
very obese subjects (n=89) and major complications (8,8 %) in this study may have affected 
the weak association noted between these parameters.  Another limitation to this study is its 
retrospective nature. The assessment of postoperative complications was based on medical 
records and thus bias of the information cannot be ruled out. It is also likely that some visits, 
e.g. to the private sector due to minor complications, are missing from this study. 
 
The amount of complications affects the cost of care. Data on health-related quality of life 
(HRQoL), before and after interventions should be collected in a further study. This approach 
would enable estimation of the number of quality-adjusted life years (QALY). Furthermore, 
when combined with costs of providing treatment, available from the hospital accounting 
records, this approach would also enable comparison of the cost-utility of services offered for 
the patients.  
 
 
In conclusion, a higher BMI is strongly associated with an increased risk of minor 
complications after RM. It is important to inform obese patients about the increased risk for 
complications and to encourage them to lose weight before surgery. Future studies are needed 
to analyze the effect of increasing BMI on the cost-effectiveness of RM. 
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Figure Legends: 
Table 1. Patient characteristics (n=453). 
Table 2. Minor and major complications after reduction mammoplasty (n=453). 
Table 3. Results of multivariate analysis: hematoma evacuations and risk factors. 
Table 4. Results of multivariate analysis: minor complications and risk factors. 
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Table 1. Patient characteristics (n=453) 
Age (mean, range), years 47 (range 18-79) 
Sternal notch to nipple distancea (mean, range), cm 
BMIa < 32, % (n) 
BMIa 32.0-34.9, % (n) 
BMIa ≥ 35.0, % (n)  
33.0 (range 22.3-48.5) 
80.2 (364) 
12.8 (58) 
6.8 (31) 
Diabetes mellitus, % (n) 3.1 (14) 
Hypertension, % (n) 20.3 (92) 
Coronary artery disease, % (n) 0.7 (3) 
BMI: body mass index, kg/m2 
a BMI n=452, sternal notch to nipple distance n=441 
 
 
 
Table 2. Minor and major complications after reduction mammoplasty (n=453). 
Minor complications Major complications 
Delayed wound healing (n) 
Lymphadenitis (n) 
Haematoma, seroma (n) 
Necrosis of skin/ areola (n) 
159 
3 
59 
17 
Wound dehiscence/ necrosis (n) 
Necrosis of skin/ areola (n) 
Infections (n) 
Haematoma evacuations (n) 
6 
4 
11 
23 
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Table 4. Results of multivariate analysis: minor complications and risk factors. 
 Std. error Sig. Odds ratio 95% confidence interval 
 
    Lower bound Upper bound 
Diabetes 0,032 0,278 1,976 0,577 6,761 
BMI 0,114 0,000 1,121 1,052 1,195 
Hypertension 0,268 0,628 0,878 0,519 1,486 
Age 0,009 0,112 0,986 0,968 1,003 
Sternal notch to nipple  0,034 0,195 1,045 0,978 1,116 
 
 
Table 3. Results of multivariate analysis: hematoma evacuations and risk factors. 
 Std. error Sig. Odds ratio 95% confidence interval 
 
    Lower bound Upper bound 
Diabetes 10 706 0,999 - 0,000  
BMI 0,084 0,002 0,766 0,649 0,903 
Hypertension 0,540 0,315 0,581 0,201 1,676 
Age 0,021 0,100 1,035 0,993 1,078 
Sternal notch to nipple  0,079 0,506 1,054 0,903 1,230 
